Collaborative Group for Adrenocortical Carcinoma Treatment: Clinical Trials

1 trial sponsored by Collaborative Group for Adrenocortical Carcinoma Treatment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Collaborative Group for Adrenocortical Carcinoma Treatment: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
Etoposide, Doxorubicin, Cisplatin - Carcinoma, Adrenal Cortical
Phase 3CompletedCollaborative Group for Adrenocortical Carcinoma Treatment3042004-06-012016-09-21

Conditions studied

Adrenocortical Carcinoma (1)

Interventions

Cisplatin (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Mitotane (1)  ·  Streptozocin (1)

Countries

Australia (1)  ·  Austria (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Britt Skogseid, MD (1)  ·  Martin Fassnacht, MD (1)

Results publications

PMID 22551107